文献速递糖尿病

墨西哥糖尿病相关超额死亡:2017-2019年与2020年全国死亡登记比较分析

Diabetes-Related Excess Mortality in Mexico: A Comparative Analysis of National Death Registries Between 2017-2019 and 2020.
PubMed 文献 · Diabetes Care · 2022-01-01

这项回顾性州级研究利用墨西哥2017-2020年成人全国死亡登记,比较2020年与2017-2019年平均的糖尿病相关死亡率。2020年糖尿病相关死亡148,437例(177/10万),2017-2019年平均101,496例(125/10万),增加41.6%,院外死亡增加89.4%,超额死亡集中在南部和社会滞后较高的州。

要点

  • 2020年糖尿病相关死亡148,437例(177/10万),较2017-2019年均值增加41.6%。
  • 院外糖尿病相关死亡增加89.4%,院内死亡减少17.8%。
  • 高血糖高渗状态和糖尿病酮症酸中毒相关死亡分别增加128%和116%。

核心结论

  • 2020年新冠疫情开始后,墨西哥成人糖尿病相关死亡增加41.6%,多发生在院外,主要归因于2型糖尿病和高血糖急症。

研究设计与样本

  • 回顾性州级研究,使用墨西哥2017-2020年≥20岁成人全国死亡登记,以ICD-10编码将糖尿病列为主要死因定义糖尿病相关死亡,并排除COVID-19为主要死因的证书。

主要发现

  • 2020年糖尿病相关死亡148,437例(177/10万),2017-2019年平均101,496例(125/10万)。
  • 2020年院内糖尿病相关死亡较2017-2019年减少17.8%,院外死亡增加89.4%。
  • 大多数死亡归因于2型糖尿病(130/10万)。
  • 与2018-2019年数据相比,高血糖高渗状态和糖尿病酮症酸中毒是死亡增加最多的两个 contributing cause(分别增加128%和116%)。
  • 糖尿病相关超额死亡集中在墨西哥南部,在社会滞后较高、COVID-19住院率较高和HbA1c≥7.5%患病率较高的州最高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate diabetes-related mortality in Mexico in 2020 compared with 2017-2019 after the onset of the coronavirus disease 2019 (COVID-19) pandemic. RESEARCH DESIGN AND METHODS: This retrospective, state-level study used national death registries of Mexican adults aged ≥20 years for the 2017-2020 period. Diabetes-related death was defined using ICD-10 codes listing diabetes as the primary cause of death, excluding certificates with COVID-19 as the primary cause of death. Spatial and negative binomial regression models were used to characterize the geographic distribution and sociodemographic and epidemiologic correlates of diabetes-related excess mortality, estimated as increases in diabetes-related mortality in 2020 compared with average 2017-2019 rates. RESULTS: We identified 148,437 diabetes-related deaths in 2020 (177 per 100,000 inhabitants) vs. an average of 101,496 deaths in 2017-2019 (125 per 100,000 inhabitants). In-hospital diabetes-related deaths decreased by 17.8% in 2020 versus 2017-2019, whereas out-of-hospital deaths increased by 89.4%. Most deaths were attributable to type 2 diabetes (130 per 100,000 inhabitants). Compared with 2018-2019 data, hyperglycemic hyperosmolar state and diabetic ketoacidosis were the two contributing causes with the highest increase in mortality (128% and 116% increase, respectively). Diabetes-related excess mortality clustered in southern Mexico and was highest in states with higher social lag, rates of COVID-19 hospitalization, and prevalence of HbA1c ≥7.5%. CONCLUSIONS: Diabetes-related deaths increased among Mexican adults by 41.6% in 2020 after the onset of the COVID-19 pandemic, occurred disproportionately outside the hospital, and were largely attributable to type 2 diabetes and hyperglycemic emergencies. Disruptions in diabetes care and strained hospital capacity may have contributed to diabetes-related excess mortality in Mexico during 2020.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bello-Chavolla OY, Antonio-Villa NE, Fermín-Martínez CA, et al. Diabetes-Related Excess Mortality in Mexico: A Comparative Analysis of National Death Registries Between 2017-2019 and 2020. Diabetes Care. 2022. PMID: 36286591. doi:10.2337/dc22-0616

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。